Tag: field

Nuclear leadership in Canada grows with federal investment

PrairiesCan funding supports first Canadian Executive Nuclear Energy Management SchoolSASKATOON, SK, June 8, 2026 /CNW/ - In our rapidly changing world, secure energy solutions...

National Kidney Foundation and U.S. Pharmacy Organizations Call for Transition to Race-Agnostic eGFR in Medication Decision-Making

NEW YORK, June 8, 2026 /PRNewswire/ -- A coalition of leading U.S. pharmacy organizations, in collaboration with the National Kidney Foundation (NKF), is urging...

New Transcribe carpet tile, LVT collection from Tarkett inspires human connectivity, expression

SOLON, Ohio, June 8, 2026 /PRNewswire/ -- From ancient etchings to contemporary icons, human beings have always had an enduring instinct to communicate through...

VINFAST’S GLOBAL REVENUE IN Q1 2026 INCREASED 42% YEAR OVER YEAR

SINGAPORE, June 8, 2026 /PRNewswire/ -- VinFast Auto Ltd. announced its unaudited financial results for the first quarter ended March 31, 2026. ...

Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey

HANGZHOU, China, June 8, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical technology company...

FREEGAME LAUNCHES FREEGAME DIAMOND, EXPANDING INTO BASEBALL AND SOFTBALL THROUGH MERGER WITH PREP

The merger brings FreeGame's full service athlete platform together with Prep's diamond sports expertise across representation, NIL, brand partnerships, and athlete education.CHARLOTTE, N.C., June...

Mercuryo Claims 60th Place in Sifted 100: Southern Europe Leaderboard, Recognising the Region’s most Innovative High-Growth Startups

LONDON, June 8, 2026 /PRNewswire/ -- Global payments infrastructure platform Mercuryo has been recognised by Sifted, a startup news service backed by the Financial Times,...

Foresee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform Trial

TAIPEI, June 8, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that Foresee's oral ALDH2 activator, mirivadelgat, has been selected to enter clinical testing in...

LG Teams with NVIDIA to Shape the Future with M.A.P. (Mobility / AI Infra / Physical AI)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- LG and NVIDIA are expanding their strategic collaboration across industries, Physical AI, AI Infra and mobility...

DL Holdings’ Fourth “Victoria Harbour Night Talk”: The AI Wave: Global Investment & Hong Kong Opportunities

HONG KONG, June 8, 2026 /PRNewswire/ -- The Fourth "Victoria Harbour Night Talk" concluded successfully on June 5 at Cloud 39, The Henderson, Central,...

Casino Group Communication

Casino Group and the Zouari Family strengthen their historic partnership to accelerate in convenience retail

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 8, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

NEW ORLEANS, June 7, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing innovative...

A New Era Begins: Cal Poly Unveils the John Madden Football Center

$45 Million Facility Honors Legendary Alumnus and Elevates the Future of Mustang FootballSAN LUIS OBISPO, Calif., June 6, 2026 /PRNewswire/ -- Cal Poly Athletics...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsField

$100 No Deposit Bonus 200 Free Spins Real Money Casinos – All iGaming Experts Report Rising Demand for Free Spins Casinos

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Lilly’s Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with...

Tag: field

Nuclear leadership in Canada grows with federal investment

National Kidney Foundation and U.S. Pharmacy Organizations Call for Transition to Race-Agnostic eGFR in Medication Decision-Making

New Transcribe carpet tile, LVT collection from Tarkett inspires human connectivity, expression

VINFAST’S GLOBAL REVENUE IN Q1 2026 INCREASED 42% YEAR OVER YEAR

Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey

FREEGAME LAUNCHES FREEGAME DIAMOND, EXPANDING INTO BASEBALL AND SOFTBALL THROUGH MERGER WITH PREP

Mercuryo Claims 60th Place in Sifted 100: Southern Europe Leaderboard, Recognising the Region’s most Innovative High-Growth Startups

Foresee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform Trial

LG Teams with NVIDIA to Shape the Future with M.A.P. (Mobility / AI Infra / Physical AI)

DL Holdings’ Fourth “Victoria Harbour Night Talk”: The AI Wave: Global Investment & Hong Kong Opportunities

Casino Group Communication

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

A New Era Begins: Cal Poly Unveils the John Madden Football Center

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us